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Abstract
In a world where microorganisms outnumber humans, the need for novel
antimicrobial agents is crucial to human health. Multi-drug resistant strains of
microorganisms have caused a worldwide crisis. Recent research studies on
antimicrobials are centered on natural compounds. Natural resources such as green tea
have been studied for the past several decades for their antimicrobial, anti-cancerous,
anti-inflammatory and numerous other beneficial properties. This particular study focuses
on the effects of green tea polyphenols (GTP) and their derivatives, Lipophilic Tea
Polyphenol (LTP), Epigallocatechin gallate (EGCG), and Epigallocatechin gallate
Stearate (EGCG-Stearate) as antimicrobial agents, antibiotic synergism agents, inhibitors
of spore formation and biofilm formation. From initial studies o f viable count, staining
techniques, to growth curves and disk diffusion studies, the green tea polyphenols are
applied to select microorganisms. The selected bacteria separated into Gram negative
bacteria: Escherichia coli, Pseudomonas aeroginosa, Serratia marcescens, ampicillin
resistant Escherichia coli and Enterobacter aerogenes; Gram positive bacteria: Bacillus
megaterium, Staphylococcus aureus, and Staphylococcus epidermidis, and acid-fast
bacteria: Mycobacterium smegmatis were used in these experiments. Kirby Bauer disk
diffusion experiments revealed all polyphenols synergistically work with more than three
antibiotics for E.coli, E. aerogenes and S. epidermidis. 1% GTP and 1% EGCG have no
synergistic effect on S. marcescens but 1% EGCG-Stearate and 1% LTP do have a
synergistic inhibition. Only 1% EGCG-Stearate had a synergistic effect with B.
megaterium. For growth inhibition 1% EGCG and 1% EGCG-Stearate were able to
inhibit the growth of a majority o f the microorganisms alone without ampicillin to a
certain extent. In the presence of ampicillin most o f the growths are completely inhibited.
Spore study revealed 10% LTP treatment had a 91% inhibition o f sporulation compared
to control spores. 10% GTP treatment resulted in an average o f 64.1% inhibition. 10%
EGCG resulted in a 100% inhibition compared to 10% EGCG-Stearate, which showed
79% inhibition. These broad studies of the endless benefits o f green tea polyphenols give
rise to many medicinal implications. From these results, it can be concluded that LTP,
GTP, EGCG and EGCG-Stearate are antimicrobial agents with EGCG and EGCGStearate being the most effective agent.
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I.
Introduction
1. Crisis of Current Antimicrobial Treatments
The medical and scientific communities are on a constant battle. This battle is
with the microscopic pathogenic microorganisms that can cause severe human infections
from the food industry to medical facilities. A patient infected with a pathogenic
microorganism is subject to risk of antibiotic resistance. These infections range from
multidrug resistant Staphylococcus aureus (MRSA) to multidrug resistant tuberculosis.
MRS A is often a deadly infection due to the lack o f treatments in today’s society45.
Multidrug resistant tuberculosis is a global threat with increasing cases by the day. All of
these new strains of microorganisms arose from once susceptible strains. Within several
years of the introduction of penicillin, microbes became resistant to penicillin45. Microbes
that were not killed by antibiotics caused severe infections such as septicemia. The crisis
of “superbugs” is occurring throughout the world with increased mortality rate for
bacteria infections10. For instance, the common ciprofloxacin, which is a broad spectrum
second generation fluoroquinolone antibiotic, is becoming ineffective. These multidrug
resistant strains of bacteria are easily passed on from human to human making them a
global threat. Often these cases end in death due to the lack o f a cure. A 2012 report
documented 25,000 patients in Europe and 63,000 patients in the United States dying
every year due to multi-drug resistant bacterial infections10. The current battle with
modem antibiotics is failing due to multidrug resistant strains o f microorganisms31.
Bacteria are resistant to antibiotics due to several factors involved. As a result of
antibiotic abuse and the high rise of mutations in microorganisms, many strains are no
longer susceptible to these drugs. Vimlence factors for any pathogenic bacteria are
regulated by many factors such as mutations22. When physicians prescribe antibiotics, it
is able to kill the susceptible microbial strains but leaves behind the strains that are not
affected by the antibiotics. This microbe can then multiply and becomes the predominant
microorganism. The antibiotics itself is not the cause o f resistance. It is actually the
environment that is created, that selects for the unsusceptible strain22. The abuse and
misuse of antibiotics by patients has led to dmg resistant strains o f microorganisms that
no longer can be cured with common single antibiotics.
Multidmg resistance can also occur when genes coding for resistance to a certain
dmg are turned on or when there is an increase in the genes for efflux pumps. Efflux
pumps are able to extmde the dmgs out o f the cell22. Bacteria are able to genetically
acquire resistance to therapeutic agents, and no longer become effective in life
threatening bacterial infections10. The need for new therapeutic agents in the battle
against pathogenic bacteria may lie in the hands o f nature. New research focuses on the
possibilities of natural products inhibiting the growth of these bacteria and decreasing
their vimlence factors in the community.
2. Antibiotics General Mode of Actions and Current Treatments
Before new therapeutic agents are studied, the current dmgs on the market must
be evaluated. Antibiotics are commonly prescribed by physicians for bacterial infections
because they either slow the growth or completely inhibit the growth of the pathogenic
microorganisms. Most of these antibiotics are produced by fungus species and derived
compounds such as penicillin. One such mechanism is that p- lactam rings covalently
bind to penicillin binding proteins and then inactivate the enzymes necessary for cell wall
10

synthesis45. Specifically, transpeptidase and carboxypeptidase is inactivated upon this
binding45. These are the same enzymes that are needed for the final transpeptidation
process of the synthesis of the cell wall45. Scientists also know, that Vancomycin which
is usually the first form of treatment for MRSA infections, inhibits bacterial cell wall
synthesis15. These cell wall inhibitors affect bacteria that contain murein or
peptidoglycan15. The cell wall is essential for structure and stability of the
microorganism. Some other antibiotics can interfere with protein synthesis such as
tetracylcines, aminoglycosides and macrolides15. These types o f antimicrobial agents
inhibit the protein synthesis process o f the bacterial cell. Chloramphenicol is a wellknown inhibitor of protein synthesis in bacterial cells19. Other antibiotics target the
essential cell membrane. Polymyxins are able to disrupt the cell membrane structure and
cause the cell to die eventually4. Antibiotics such as polymyxins work most effectively on
Gram negative bacterial cells 45. Another important type of antibiotic is known as a
competitive inhibitor 10. This type o f antibiotic is able to competitively inhibit the
metabolic pathway of the bacterial cell such as sulfonamides19. All of these antimicrobial
agents are able to target a specific component of the bacterial cell. The need for new drug
targets is crucial to patients infected with pathogenic bacteria. Often when one antibiotic
fails, physicians will administer a multiple o f different antibiotics to inhibit the growth of
a pathogen. When more than one therapeutic agent works together, it is known as a
synergistic effect. The twelve antibiotics chosen for one of the studies conducted in this
research are Ampicillin (AM 10), Bacitracin (BIO), Cephalothin (CF30),
Chloramphenicol (C30), Doxycycline (D30), Erythromycin (E l5), Gentamicin (GM10),
Penicillin (P10), Polymyxin (PB300), Rifampin (RA5), Streptomycin (S10), and
Tetracycline (TE30). These twelve antibiotics cover the range o f different targets and are
the most common prescribed antibiotics in today’s drug market.
3. Natural Products and Green Tea
The constant need for novel antimicrobial treatments is driving drug producing
companies to scavenge many natural products. Natural compounds from plants have
traditionally been known to treat microbial infections10. The plant extracts have been
used for centuries to heal cuts, bruises and other medical emergencies4. The plant extracts
have these beneficial properties because of the polyphenols found within their cells.
Polyphenols are found in a variety of plants including green tea leaves and grape seeds33.
Along with tea polyphenols, other different types of polyphenols such as tannins are also
found in many plant species33. These tannins have similar activity to the catechins found
in tea33. For instance grapefruit contains naringenin and lemons contain eriodictyol 9.
Several natural compounds like cerulenin and thiolactomycin are known antibacterial
agents46. Plant extracts have a number o f low molecular weight metabolites46. These
metabolites could have arisen as an evolutionary response to microbial attacks on the
plants46. They serve as important defense mechanism against pathogens and animal
herbivores9. If plants can prevent microbial attack, then humans could potentially use
these metabolites against human pathogenic microorganisms.
These antimicrobial metabolites are found in plants such as green tea46. The
antimicrobial activity the green tea polyphenols have been related to its effect on the cell
wall of the microorganism32. In the past several decades an immense amount o f studies
have been conducted on this valuable green tea extract. Nature’s most powerful
antioxidant is green tea and it is the most consumed beverage across the globe1. This
11

pharmacological activity of green tea has many uses from anti-cariogenic, anti
inflammatory, anti-cancer, and antimicrobial43. Most studies have conducted
antimicrobial activity using crude extracts of the tea. Some studies have used pure
extracts for the same studies resulting in different outcomes4. It is essential to know the
contents of the extracts before proceeding to an experiment. This will allow the
researcher to pinpoint the active ingredient.
Green tea is the leaves of the perennial tree tea Camellia sinensis3. The difference
between green tea, black tea and oolong tea is that green tea is not fermented. The apical
buds and the leaves are the source of the c atech in s. Catechins are flavonoids that have a
large impact on human health based on many research studies28. It is often seen on the
news and infomercials that green tea is placed in new cosmetic lotions and a great dietary
supplement. Catechins are known to inhibit enzyme activity of ornithine decarboxylase,
urokinase, and protein kinase. Some of these enzymes are involved in the progression of
cancerous cells28. Catechins have been shown to inhibit the growth o f cancerous human
colon and hepatic epithelial cells28. Green tea polyphenols (GTP) are known also known
to decrease oxidative damage30. All o f these properties make green tea polyphenols the
ideal antioxidant. The polyphenols are only 20% o f the dry green tea le a f2. Green tea
contains galloyl and nongalloyl catechins2. These catechins include epigallocatechin
gallate (EGCG), epigallocatechin (EGC), epicatechin gallate (ECG), and epicatechin
(EC )20. According to an HPCL-LC/MS study the major constituents o f green tea is
epigallocatechin gallate36. The other two major compounds identified are caffeine and
epigallocatechin36. Epicatechins have three hydroxyl groups in the B ring. Antioxidant
activity is known by structures that have the most hydroxyl groups20. A previous study
that conducted a bioassay guided fractionation to observe the composition of green tea
revealed that out of all the catechins, the two strongest antimicrobials are ECG and
EGCG32. EGCG is an isomer of the catechin ECG31 and the molecular weight o f EGCG
is MW 45 831. The primary catechin found in green tea is EGCG has important medicinal
benefits for humans31. Figure 1 demonstrates the molecular structures of the catechins.

Figure 1. Molecular Structure of EC, EGC, ECG and EGCG
One of the issues with green tea polyphenol’s use is that it is not stable. The green
tea polyphenols need to be modified to form a lipophilic tea polyphenol (LTP) which is
soluble in any lipid medium and is a more stable compound26. This compound can be
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applied to a topical application. This allows mores uses for the compound. Lipophilic tea
polyphenol (LTP) is usually prepared by catalytic esterification of green tea polyphenol
with hexadeconoyl chloride26. A new long chain acyl derivative of epigallocatechin
gallate was isolated from this lipophilic tea polyphenol26. The EGCG was isolated by
high speed countercurrent chromatography3. EGCG is water soluble and can be
lyophilized by esterification with fatty acids 48. The incorporation of fatty acids has been
shown to increase antioxidant activités48. These molecules also have a higher antiviral
activity48. The ester form of EGCG has increased beneficial properties compared to the
parent molecule. EGCG has a four ring structure and also has eight hydroxyl groups48.
EGCG is not dissolved in hydrophobic media and only dissolved in water48. EGCG is
hydrophilic in nature and does not penetrate within a lipophilic environment48. This can
be a problem when EGCG is administered orally and is unable to absorb within a cell
because of its hydrophilic nature. When the structure is modified to become lipophilic it
is able to absorb into the lipid layer of a cell. The structural modification o f the catechins
can improve the benefits of the catechins such as a greater antimicrobial activity26. EGCG
has poor membrane permeability, low chemical stability and is usually metabolized
rapidly21. It has been shown that addition of long acyl chains to EGCG enhances its
antiviral activity21. These derivatives have a higher beneficial activity. Modification of
the compound can enhance antimicrobial activity. The catechins in polyphenols belong to
the flavan-3-ol class of flavonoids. Catechins are thermo stable and they are also stable in
acidic conditions . Designing a compound that has a greater antimicrobial activity will
be the next step in the potential usage of EGCG as a therapeutic drug. The extracts need
to be pure and free of contaminants that may hinder its beneficial properties43. The pure
extracts should have a greater effect as a therapeutic agent.

Figure 2. Esterification of EGCG

It has been determined by many experiments that the chemical compounds
responsible for the beneficial effects of green tea are EGCG43. EGCG is able to penetrate
and work as an antimicrobial agent when it prevents the growth of the bacterial cell.
EGCG has different affinities towards the different cell wall components o f Gram
negative and Gram positive bacteria5. Studies have shown that EGCG activity against
Enterobacteriaceae is less active and effective compared to Gram positive
13

microorganisms21. Previous research studies suggest that EGCG disrupts the membrane
o f the pathogenic bacteria and is able to adhere to Gram positive bacteria better than
Gram negative bacteria3. Gram positive bacteria are more susceptible to EGCG than
Gram negative bacteria as a direct result o f the cell membrane and the composition o f the
cell peptidoglycan layer8. EGCG can bind directly to the exposed peptidoglycan layers of
Gram negative bacteria because of their surrounding membranes8.
4. Microorganisms of Study
The chosen microorganisms in these particular studies include the Gram positive
species Staphylococcus epidermidis, Staphylococcus aureus, and Bacillus megaterium;
five gram-negative species: Enterobacter aerogenes, Serratia marcescens, Pseudomonas
aeruginosa, ampicillin resistant Escherichia coli and Escherichia coli; as well as one
acid fast organism, Mycobacterium smegmatis. Each o f these microorganisms can be
potential pathogens and cause harm to humans if they are given the proper nutrients and
incubation temperatures. Some are also found naturally as part o f our microflora. These
organisms are potentially pathogenic and studying them in detail can bring about possible
alternative treatments.
Gram negative microorganisms are characterized for several distinct properties
such as their thin peptidoglycan layer. Peptidoglycan is a complex of cross linked
polysaccharides and peptides31. Gram negative microorganisms do not retain crystal
violet dye and are counter stained with safranin. This gives them the distinct pink color
under the microscope37. Pseudomonas aeruginosa are Gram negative pathogenic bacteria
that are associated with many detrimental effects such as food spoilage and biofilm
formation44. They are present in many wounds o f patients14. The general public is most
familiar with Escherichia coli due to its high publicity as a pathogen. E. coli can cause
infections in wounds, urinary tracts and abdominal cavity; diarrhea and many other
diseases23. E. coli is found in our normal gut microflora. Enterobacter aerogenes is part
of the Enterobacteriaceae Family and is known to cause many bacterial infections that are
hospital acquired21. The other organism of this study is Serratia marcescens, which is a
species of the Gram-negative, rod-shaped bacterium in the family Enterobacteriaceae.
Serraita is similar to E. coli because it can cause infections.
It is important to study both Gram negative and Gram positive microorganisms as
they differ morphologically. The cells of Gram positive bacteria are made up o f thick
peptidoglycan layers37. This makes Gram positive bacteria less susceptible to
disinfectants and treatments37. The efficiency o f disinfectants is dependent on many
factors such as pH and temperature37' Staphylococcus aureus is a pathogen that causes a
range of diseases that can be deadly. The diseases include pneumonia, septicemia,
bacteremia, and numerous other aggressive infections4. Methicillin resistant
Staphylococcus aureus (MRSA) is resistant to multiple antibiotics and is a difficult
infection to treat15. If it is not caught in the early stages of infection, the outcome can
result in death of the patient. Staphylococcus microorganisms are some o f the best known
of the many microorganisms and are commonly found in the mucous membranes and
skin of humans19. They can cause many diseases in humans if they are the pathogenic
strain. The other Staphylococcus species of study is Staphylococcus epidermidis which is
a spherical non motile facultative anaerobic microorganim37. It is found on the skin and
mucous membrane of many mammals. Other Gram positive microorganisms include the
Bacillus species. The Bacillus species include the anthrax causing Bacillus anthracis and
14

spore forming organisms7. Spores formed by Bacillus species are the main concern for
the medical and food industries due to their difficult eradication7. In this study Bacillus
megaterium is used because of its large size and spore forming abilities.
The last organism of study is Mycobacterium smegmatis which belongs to the
same family as Mycobacterium leprae and Mycobacterium tuberculosis. This model
organism of study is important in understanding leprosy and tuberculosis. Mycobacterium
smegmatis is a very slow growing microorganism and is similar to many pathogenic
bacteria in the same family such as Mycobacterium tuberculosis. Mycobacterium
smegmatis is known as an acid fast microorganism because o f its mycolic acid, waxy,
impermeable membrane. They are difficult to stain with water based stain and only pick
up the acid fast stain. Studying this microorganism will lead us understand its pathogenic
relatives.
5. Danger of Endospores
It is important to study the Bacillus species of microorganisms because they are the
ones that have the ability to form endospores. This endospore formation is very important
to the medical and food industry. Many foods can have a small number o f bacteria cells
present that are resistant to heat. This small number can reproduce depending on the
temperature and condition of the food. It is important to study the number o f cells needed
to reproduce and cause disease in the field o f food microbiology. There is an uneven
distribution o f dormancy in endospore populations7.The endospore germination rate is
related to the actual number of cells present, essentially at a higher endospore density, a
greater percentage of germinating endospores will be available7. Bacterial endospore
germination can be measured using several methods such as measuring turbidity of
suspensions, increase in endospore staining, loss of heat resistance and loss of
reffactility . The extent of germination can also be measured via direct microscope .
Thermophilic bacteria can spoil foods. The formations of these endospores in food are
difficult to eradicate and present problems when consumed. The bacterial endospore coat
is made up of structural protein instead o f peptide-amino-sugar complexes that are found
in vegetative cell walls27.When food is prepared it undergoes several processes that affect
the microorganisms present in food. Stresses such as extreme temperatures, acidic
environments, salt conditions and preservative additions are ways to prepare food19.
These stresses can cause microorganisms to undergo several growth changes. There is
great concern for the safety and regulation of processed food. The ability to form
endospores allows the Bacillus species o f microorganisms to survive extreme
environmental stresses40. Consumers are cautious of food additives that prevent food
spoilage but have detrimental health effects. Additives such as sodium nitrate, BHT,
propyl gallate, and aspartame are just the few that have been linked to cancer causing
agents23. The need for natural preservatives has become the focus o f attention for the
food industry. Catechins that are found in green tea are safe for consumption and have
been consumed by millions for centuries. Previous studies have shown that green tea
polyphenols have an antimicrobial effect on Bacillus stearothermophillus29. This
particular study revealed that the endospores o f Bacillus sterothermophilus are inhibited
by the green tea polyphenol29. Other similar microorganisms such as Clostridium
thermoaceticum endospores have also been inhibited by the green tea polyphenol. The
green tea polyphenols make the endospores less heat resistant which has many
implications in the food industry. This research began as a result of the observation that
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canned tea is resistant to spoilage29. Not much is known on the exact biochemical
reactions that are involved in endospore germination40. Pressure can induce germination
o f bacterial endospores along with other stresses40. If the natural green tea polyphenols
can prevent germination of the endospore forming microorganism, a great breakthrough
in the food industry can be presented. This particular study will apply GTP, LTP, EGCG,
EGCG-Stearate and observe the germination rates o f the Bacillus species.
6. Biofilm Formations
Besides endospores, another microbial mechanism makes it very difficult to eradicate
the pathogenic bacteria, and that mechanism is biofilm formations. Current research is
demonstrating that most microorganisms in nature grow on surfaces as attached
communities24. Biofilms are bacterial cells that are organized in a community
aggregation and are embedded in a matrix of extracellular polymeric substances16..
Biofilms have a unique heterogeneous architecture that can surpass any treatment applied
to them 24. This unique architecture gives rise to the resistant and stable colony of
microorganisms. Biofilms are formed by an extracellular polysaccharide (EPS) matrix6.
Research has shown that the chemical composition o f the matrix is made of water,
exopolysaccharide, DNA, RNA, proteins and ions12. There is great interest in biofilms
because research has shown that microorganisms behave differently in biofilms than they
do in the planktonic state. The resistance o f current treatments is significantly decreased
for biofilms of the same microorganism in the planktonic state. The production o f an
extracellular matrix is a strategy used by microorganisms to provide structural support
and also aides in surface attachment12. The biofilm allows for a greater survival rate for
the microorganisms and almost acts like a defense mechanism for the population of
bacterial cells12. They thrive in low nutrient conditions and are resistant to common
antimicrobial treatments12. Pseudomonas aeruginosa is a common study guide for
biofilm studies. It forms biofilms in standing cultures in the form o f a pellicle. Pellicles
are one type of biofilm that form at the air liquid interface in a culture tube. Under
different environmental conditions, Pseudomonas aeruginosa is able to form different
biofilms. Another type of biofilm formed by Pseudomonas aeruginosa are the solid
surface associated biofilms, which is the most common form o f biofilm formed. The
actual formation of the extracellular matrix is the key factor determining the success o f
biofilms. To treat biofilms the exact constituents o f the biofilm extracellular matrix needs
to be determined. The genes involved in the formation of the pellicle biofilm in
Pseudomonas aeruginosa have been characterized as the pel genes. The pel genes are
involved in the production of carbohydrate that is required for the structural component
of the biofilm. With mutant strains of the pel genes, Pseudomonas aeruginosa is unable
to from this carbohydrate complex and the biofilm is easily washed away with slight
force. New surfaces can become colonized by daughter cells from existing biofilms14.
Biofilm producing Pseudomonas aeruginosa in the lungs cause chronic infection in
cystic fibrosis patients14. One of the main features of biofilm infections in humans is that
they are resistant to any of the immune defenses present and most importantly they are
resistant to current antibiotic treatments14. This makes the biofilms of Pseudomonas
aeruginosa very dangerous. Pseudomonas aeruginosa has the highest proportion of
regulatory genes seen in a bacterial genome and this can be useful in the study of
biofilms14. This particular study focuses on the effect o f the green tea polyphenols on
biofilm fonnations. Another organism Pseudomonas fluorescens will also be used in the
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future as a model biofilm forming microorganism. Upon the study o f biofilms, one
cannot disregard the very true biofilm located in human oral cavities. Dental plaque is a
biofilm formation on the enamel of teeth6. The structure o f the polysaccharide matrix
plays a role in the virulence of plaque and tooth decay6. The exopolysaccharide matrix
can be influenced by the surrounding environment and changes with time. The
composition o f dental plaque composes of approximately 20% glucan, 2% fructan, 40%
protein and a large percentage of water in situ6. Streptococcus mutans release
glucosyltransferases that aid in dental plaque. Glucosyltransferases are absorbed to
enamel and produce glucans6. This is the site where microorganisms can colonize and
form an insoluble matrix6. Glucosyltransferases are expressed in the genome o f
Streptococcus mutans in three different genes known as GtfC, GtfB, and GtfD6. The
biofilm starts to appear on a surface when a flow o f liquid medium passes the planktonic
cell and some of the bacterial cell actually attach to the surface. After several hours after
attachment, the adhesion is irreversible14. This is because o f the presence of the Pilli and
the glycolcalyx produced by the bacteria cells. The genes for biofilm have been turned
on. Streptococcus mutans is the main cause of dental caries in humans 41. Streptococcus
mutans is able to produce glucosyltransferases (GTFs) that form the extracellular
polysaccharide matrix for the bacteria to thrive in 41. Biofilm formations are one o f the
main factors leading to dental caries41. This information is very critical to the study of
biofilms. If the studies of biofilm prevention can be established, they can be used to treat
dental plaques. The dental plaques can be treated with green tea polyphenols with
potential synergistic effects with modem mouthwashes and toothpastes.
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II.

Objectives of Study

1. Profile Synergistic Effect o f Green Tea Polyphenols, GTP, LTP, EGCG and
EGCG-Stearate.
a. Detect Colony Forming Unites (CFU) under the treatment o f each
green tea polyphenol.
b. To determine the synergistic effects o f GTP, LTP, EGCG, and EGCGStearate with 12 select antibiotics, Kirby Bauer method and growth
inhibitions were conducted.
2. To study the generation time of each o f the microorganisms, a growth over a
period of time was analyzed.
3. To study the effect of the green tea polyphenols on endospore germination,
Bacillus megaterium was used to produce endospores and apply treatment.
4. To study the effect the green tea polyphenols on biofilm formation, two
microorganisms known to form biofilm, Pseudomonas aeroginosa and
Pseudomonas fluorescens is used. Biofilms are grown and treated with the
polyphenols to observe effect.
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1.

2.

III.
Materials and Methods
Cultures of nine strains of microorganism
a. There are nine microorganisms that were constantly maintained and tested
for in each experiment. The organism strains are Gram negative bacteria:
Escherichia coli, Pseudomonas aeroginosa, Serratia marcescens,
ampicillin resistant Escherichia coli and Enterobacter aerogenes; Gram
positive bacteria: Bacillus megaterium, Staphylococcus aureus, and
Staphylococcus epidermidis, and acid-fast bacteria: Mycobacterium
smegmatis. The cultures were maintained in either Mueller Hinton agar
plates, nutrient agar plates, Mueller Hinton Broth or nutrient Broth.
Mueller Hinton agar and broth prepared in distilled water before being
vigorously boiled and autoclaved. The microorganisms were grown at
37°C with consistent shaking at 250 rpm speed overnight. Only Serratia
marcescens was grown at room temperature 24 °C. Fresh stocks were
prepared from the 4° C storage.
b. Microorganisms were also stored in -80 °C refrigerator storage. Each
microorganism is made into a frozen stock for future reviving. A solution
of 30% glycerol (v/v) was obtained with 30 ml of glycerol with 70 ml of
distilled water. The solution was transferred to screw cap bottle and
sterilized by autoclaving at 121 °C. After autoclave and cooling the
glycerol, 500 pi of sterile 30% glycerol was placed into a sterile 2 ml
micro-centrifuge tubes. 500 pi of the microorganism was added to the
micro-centrifuge tube. Each tube was placed in a micro-centrifuge tube
holder. Each tube was labeled with the proper microorganism, date and
location. The tubes were placed into a -80 °C refrigerator storage.
Preparation of medium for microorganisms
a. Nutrient Broth (NB) and Nutrient Agar Plates (NA) were prepared
according to manufacturer directions. The directions called for 38grams of
powder into 1 liter of deionized water into a 2 liter Erlenmeyer flask and
heat-stirred on a hot plated with a magnetic stir bar. The solution is
allowed to completely dissolve. The solution is autoclaved at 121 °C at the
liquid setting. For Nutrient Agar Plates, the solution is allowed to slightly
cool for 20 minutes and poured aseptically into petri dishes. The agar
plates are stored in 4 °C until needed for further testing and experiments.
b. Mueller Hinton Agar Plates (MH Plates) and Mueller Hinton Broth (MB)
were prepared according to manufacturer. The protocol calls for 28grams
of powder were dissolved in a 2 liter Erlenmeyer flask. The Erlenmeyer
flask was placed on a hot plate and a sterile magnetic stir bar was placed
into the flask. The solution was then autoclaved at 121 °C at cycle P5
(liquid cycle). The ingredients in the Mueller Hinton Broth are composed
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3.

of 300g beef extract, 17.5g casamino acid, 1.5g starch and 17g agar. The
solution was removed by using heat gloves from the autoclave and
allowed to slightly cool for 20 minutes before being poured into petri
dishes. The flame under the hood is placed on to flame the tip of the
Erlenmeyer flask before each pour. The agar plates are stored in 4° C until
needed for further testing and experiments. For the broth, the solution is
allocated among sterile cap bottles and stored into the 4° C cold room.
Preparation of Ampicillin

4.

a. Ampicillin purchased from Sigma Aldrich (AO 166-5G) is prepared by
dissolving appropriate grams into sterile water. The grams are weighed out
on automatic scale. The powder ampicillin is stored at 4 °C tightly sealed
with paradigm.
Preparation of Green Tea Polyphenols
a. Green Tea Polyphenol (GTP) and Epigallocatechin Gallate (EGCG): the
preparation of GTP and EGCG included taking extracted powder
purchased from Camellix LLC. Solute was dissolved in sterile, autoclaved
Mueller Hinton Broth to the desired concentration. The solution was
vortexed for approximately 1 minute on low setting for complete
homogenous solution.

5.

b. Lipophilic Green Tea (LTP) and Epigallocatechin gallate Stearate (EGCGStearate): the preparation of LTP EGCG-Stearate included taking
extracted powder purchased from Camellix LLC. Solute was dissolved in
sterile 200 proof Ethanol and followed same procedure as GTP and EGCG
preparation.
Viable Count
Overnight cultures of bacteria were prepared in Mueller Hinton broth.
Cultures were diluted in Mueller Hinton broth to a 0.2 OD at 600nm using
Spectrophotometer. Mueller Hinton agar plates were prepared as illustrated in
the flow chart in Figure 2. A series dilution is performed using a fresh culture
of bacteria stock (see below). Label sterile micro-centrifuge tubes with the
corresponding dilution in order. Sterile small 60mm x 15mm agar plates are
taken from storage and allowed to reach room temperature under the hood for
approximately 20 minutes. 0.02g/10mL of ampicillin prepared in sterile water.
0.05g of LTP and EGCG prepared in 5mL o f sterile ethanol and Mueller
Hinton, respectively. Label all agar plates with corresponding microorganism
and drugs. 50 pi of ampicillin sterilely placed onto agar plates. Using sterile
spreader spread evenly and allowed to dry for 10 minutes. Sterile spreader has
been sterilized with alcohol and heat treated. The plates are placed on a
rotating spreader for even distribution. 50 pi o f either LTP or EGCG sterilely
placed onto agar plates and allowed to dry for 10 minutes after spreading
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evenly. Finally 50 pi of microorganism is added to agar plate and spread
evenly. Plates are placed in 37° C incubator for 24h. Viable count is recorded.
Dilution 50pL per 60 X 15mm Plate

Figure 3. Flow Chart of Dilutions
6.

7.

Growth Curve
a. Standard growth curves are generated for each of the microorganisms. The
overnight shaken culture were diluted to a 0.1 A at 600nm for a total o f
1OmL in Mueller Hinton Broth. This A6oo is the time zero reading. The
culture was then placed into a 37 °C incubator shaker at 250 rpm. Every
hour the A6oo was recorded for a total o f six hours. The last reading was a
24 hour reading the next day. Three repeatings were conducted for each o f
the microorganisms.
96 Well Microtiter Plate Growth Monitor
a. Stock solutions of 10% o f EGCG, EGCG-stearate and ampicillin were
prepared in 5mL stock. EGCG and ampicillin are dissolved in Mueller
Hinton broth and water, respectively. EGCG-stearate is dissolved in 95%
ethanol. Overnight cultures o f Escherichia coli, ampicillin resistant
Escherichia coli, Serratia marcescens, Bacillus megaterium,
Staphylococcus aureus, Staphylococcus epidermidis, and Mycobacterium
smegmatis were diluted to an OD6oo of 0.3 A. Total volume in 96 well
plate reader was lOOpL. 1% EGCG, 1% EGCG-stearate, 5% EGCG, 5%
EGCG-stearate and 1% ampicillin were added to respective wells along
with 10 pL microorganism. Control consisted o f lOOpL of microorganism
only and lOOpL of the blank for each 1% EGCG, 1% EGCG-stearate, 5%
EGCG, 5% EGCG-stearate and 1% ampicillin. OD6oowas observed every
hour for six hours then after 24 hour final reading. Percent inhibition was
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determined by relative growth for each condition and microorganism.
Below in Figure 4 is the 96-well plate set up.

Figure 4. Microtiter Plate with Polyphenols and Microorganisms

8.

Kirby Bauer Method
a. Six isolates were individually inoculated onto Mueller Hinton agar plates
using sterile swabbing technique. Using a sterile cotton swab the bacteria
was inoculated to achieve a confluent layer o f growth. The twelve
antibiotics; Ampicillin (AM 10), Bacitracin (BIO), Cephalothin (CF30),
Chloramphenicol (C30), Doxycycline (D30), Erythromycin (E l5),
Gentamicin (GM10), Penicillin (P10), Polymyxin (PB300), Rifampin
(RA5), Streptomycin (S10), and Tetracycline (TE30) were treated on six
bacteria using the antibiotic disk dispenser. Each antibiotic disk was
saturated with 25 pL o f either: 1% GTP, 1% LTP, 1% EGCG, and 1%
EGCG-Stearate. The antimicrobial activity was evaluated with three
repeatings by using Kirby-Bauer method. The zone of inhibition (ZOI)
was measured in millimeter across the diameter o f each zone. The
susceptible (S), Intermediate (I), and Resistant (R) properties o f each were
determined based on the antibiotic profile chart below. The Kirby Bauer
Method of study is very important to study the susceptibility of
microorganisms. Numerous antibiotics and agents can be used
simultaneously and observed on the growth of each microorganism. The
susceptibility is observed through the presence or absence o f a zone of
inhibition around the disk with the antibiotic or study agent. The size of
the disk is 6mm and if no inhibition is present, a data result o f 6mm would
be noted. This is noted in letter B in Figure 5. If a zone o f inhibition is
present, the diameter of the zone is measured as indicated by letter A in
Figure 5. Letter C demonstrates a weak zone of inhibition.
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*B = No Zone of Inhibition (6mm disk included)
*C = Partial/Weak Zone of Inhibition
Figure 5. Kirby Bauer Disk Diffusion Method Example

Figure 6. Kirby Bauer Disk Diffusion Dispenser

Table 1: Kirby Bauer Disk Diffusion Categories of Susceptible, Intermediate and
Resistant
9.

Endospore Study
a. Bacillus megaterium was incubated on a modified nutrient agar plate
(supplemented with 0.06 g of M gS04 and 0.25 g o f KH2P 0 4 per liter) at
37 °C for 10 days to induce endospore formation. After 10 days a
Schaeffer Fulton stain was conducted to observe the endospore vs.
germinated cell count. The endospores were then purified by
centrifugation at 10,000 rmp for 10 minutes. The supernatant is discarded
and the endospores are suspended in 400 pL o f sterile DI water. The
endospores are vortexed for homogenous solution. The endospores are
boiled for 20 minutes at 100 °C. Next the green tea polyphenol treatment
is added. 1%, 5%, and 10% GTP, LTP, EGCG and EGCG-Stearate is
added for two hours. The two controls with no treatment and with and
without boiling should not have the green tea polyphenols. A serial
dilution of 10~2, 10"3 and 10-4 was conducted before plating 100 pL o f the
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10.

cells onto nutrient agar plates. The plates are incubated at 24 hours and
colony counts are recorded.
Biofilm Assay
a. Trypticase Soy Broth was prepared with the addition o f 1g o f NaCl and 1g
of Glucose per liter to induce biofilm formation. This is the media used to
grow the Pseudomonas aeruginosa and Pseudomonas fluorescens cells.
b. Crystal Violet Microtiter Plate Assay: Fresh cultures o f Pseudomonas
aeruginosa and Pseudomonas fluorescens were prepared. A stock o f 0.1%
of crystal violet in DI water from the 20% crystal violet was prepared. 1
mL of the crystal violet and 199 mL o f DI were mixed to make 1%
concentration. A stock o f 30% acetic acid was prepared from the 100%
acetic acid. The total stock made used 150mL o f acetic acid into 350 mL
water. Plate 1 was the control with only the microorganisms. Plate 2 was
the control at 24 hours. Plate 3 was the control at 48 hours. Plate 4 was the
control at 72 hours. Each of the plates were washed with 2.5 mL o f 1%
crystal violet. After an incubation o f 20 minutes, the planktonic cells were
removed via aspiration. lmL o f sterile water was used to wash the excess
crystal violet. Sterile water was removed by aspiration, and 4mL o f 30%
acetic acid was added. The absorbance at 600nm was recorded for each
well.
c. Air-Liquid Interface Assay: Overnight cultures o f Pseudomonas
aeruginosa at 37 °C at 250 rpm was obtained and diluted to an OD60o o f
20mL of culture placed into 50 mL confocal tube as shown in Figure 7.
The control had no polyphenols. The treatments included 0.5% GTP, 0.5%
LTP, 1% GTP and 1% LTP. Microscope slides were sterilized via UV
exposure under the hood, were placed into the confocal tube. The biofilm
was grown for four days. Next slides are microscopically viewed for
number of biofilm formed cells present at the air-liquid interface.

Figure 7. Air-Liquid interface Assay
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IV.

Results/ Discussion

1. Microbial Growth
To observe the natural growth o f the nine microorganisms, a grow curve was
generated. Each of the nine microorganisms were observed over a period o f 15 hours and
growth was monitored. Below are the growth curves demonstrating the typical growth
stages at optimal temperature. Each o f the microorganisms undergoes the typical growth
phases of lag phase where the organism is inoculated and adjusts to the media. As seen
from Figures 8-16 each o f the microorganisms undergo a period o f lag phase, exponential
growth, stationary phase and eventually cell death. The OD reading begins to drop
indicating a decrease in the actual number of cells. The bacteria are in the closed culture
tube that has a limited number of nutrients and media. When the nutrients are depleted
and the population has reached its maximum capacity, the microorganisms begin to show
loss of viability. Figure 8 displays the growth of E. coli that reaches stationary phase.
Figures 9, 10, 12, 14, 15 and 16 demonstrate similar curves o f reaching the stationary
phase. Figures 11 and 13 of E. aerogenes and B. megaterium respectively show after 15
hours reaching the death phase. These growth curves are valuable for determining the
changes in growth that occurs with green tea polyphenol treatments.

Figure 8. Growth curve of Escherichia coli

26

Figure 9. Growth curve of Escherichia coli Resistant

Figure 10. Growth curve of Serratia marcescens

Figure 11. Growth curve of Enterobacter aerogenes

Figure 12. Growth curve of Pseudomonas aeruginosa

Figure 13. Growth curve of Bacillus megaierium

Figure 14. Growth curve of Staphylococcus aureus
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Figure 15. Growth curve of Staphylococcus epidermidis

Figure 16. Growth curve of Mycobacterium smegmatis
It is important to know the generation time of each of the microorganisms as they
differ greatly. The generation time reveals how fast the bacteria are growing in the
particular media and condition. To study each of the microorganisms, they were observed
in their optimal growth conditions. The generation time of each o f the microorganisms
was determined from the general equation: g = (logio Nt - logio N0) / logi02. The
generation time of bacteria is the time it takes for the culture to double in population size.
According to the generation times calculated in Table 2 E. coli has generation time o f 20
minutes. The generation time for M. smegmatis is the longest time at 700 minutes,
indicating that M. smegmatis grows very slowly compared to the other microorganisms.
The turbidity studies show that cells have multiplied within the observed time period. The
microorganisms were observed in Mueller Hinton Broth with the proper nutrients needed
for growth.
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Bacterium

Generation Time (minutes)

Escherichia coli

20

Escherichia coli Resistant

21

Serratia marcescens

45

Enterobacter aerogenes

35

|

Pseudomonas aeruginosa

40

|

Bacillus megaterium

25

Staphylococcus aureus

30

|

Staphylococcus epidermidis

25

I

Mycobacterium smegmatis

700

Table 2. Calculated Generation Time of Nine Microorganisms

2. Colony Forming Units in the Presence of LTP with or without
Ampicillin
To initially study the effects o f LTP on bacteria, E. coli was chosen as the Gram
negative example to evaluate in a viable count study. The idea behind viable count
method is that each cell must be alive to give rise to a colony and every colony is formed
from one initial cell. Due to its presence in our normal gut flora and its potential
pathogenic properties, E. coli infections are very critical to treat and some cases of
infection are resistant to ampicillin. If a natural compound can work synergistically with
current antibiotics, a greater inhibition should be observed. This study particularly
observed the combination effects of ampicillin and LTP on the bacterial colony counts.
To answers questions of LTP and ampicillin synergistic effects, ampicillin and LTP were
applied to the agar plates before plating the bacteria. From previous studies on the green
tea polyphenols, 1% appears to have the greatest effect, being the minimum inhibitory
concentration. 1% LTP was used in a viable count study. To prevent overcrowding the
cells and achieving a countable range o f colonies, a serial dilution was conducted. The
dilutions 10‘3, 10"4, and 10'5 were carried out on the cells before plating. 1% LTP was
applied with or without ampicillin. The 10" dilution plates had a viable count larger than
1000 colonies. The ideal dilution was determined to be 10'4 with the ideal number of
colonies in the countable range of 150-400. As seen in Figure 17 Similar to the E. coli
study, all three microorganisms show the lowest colony count in the treatment with both
1% LTP and ampicillin. For Staphylococcus aureus ampicillin works just as well with the
addition of 1% LTP, indicating no synergistic effect. With Staphylococcus epidermidis
we see the best synergistic effect with the lowest number o f colonies with LTP.
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As seen in Table 3 with the addition o f 1%LTP, the percent inhibition of E. coli
increases from 37.9% to 74.9%. From this colony forming unit study it appears the Gram
positive organisms are more susceptible to the treatments. For all the Gram positive
microorganisms with the addition of the 1% LTP to the ampicillin treatment, the percent
of inhibition increases. The greatest percent o f inhibition is observed with B. meg at a
99.5% inhibition of colony forming units.

lYiicruurganiMö

Escherichia coli

1% Ampicillin

37.9%

Escherichia coli

1% Ampicillin and 1% LTP

74.9%

Staphylococcus aureus

1% Ampicillin

98.9%

Staphylococcus aureus

1% Ampicillin and 1% LTP

98.9%

Staphylococcus epidermidis

1% Ampicillin

99.1%

Staphylococcus epidermidis

1% Ampicillin and 1% LTP

99.4%

Bacillus megaterium

1% Ampicillin

97.5%

Bacillus megaterium

1% Ampicillin and 1% LTP

99.5%

Table 3. Percent Inhibition of 1% Ampicillin with or without 1% LTP
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400

Escherchia coli IO'4 Viable Count with Ampicillin and 1% LTP

335

Treatment Combinations

300
o 200
100

E. coli 10-4

1500

E. coli 10-4 + amp

E. coli 10-4 + am p + l% LTP

Staphylococcus aureus lO*4 Viable Count with Ampicillin and 1% LTP

1280

Treatment Combinations

H000
| 500

S. aureus 10-4

2000

13

13

S. aureus 10-4 + amp

S. aureus 10-4 + amp + 1% LTP

Staphylococcus epiderm idis 10-4 Viable Count with Ampicillin and 1%
LTP Treatment Combinations

.si 500
3L000
500

S.epi 10-4

15

10

S.epi 10-4 + amp

S.epi 10-4 + amp + 1% LTP

4480 Bacillus m egaterlum IO-4 Viable Count with Ampicillin
and 1% LTP Treatment Combinations

B. mega 10-4

113

19

B. mega 10-4 + amp

B. mega 10-4+ amp + 1% LTP

Figure 17. Treated Colony Forming Units
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Figure 18 displays the viable count study o f E. coli control, with 1% Ampicillin,
and 1% LTP. The number of colonies is less with the treatment of LTP and ampicillin as
compared to the control and ampicillin alone. This is very promising results for the initial
studies of LTP as a synergistic antimicrobial agent. The treatment must work to kill off
some cells and result in a lower colony count number at the end o f the incubation period.
There is a degree of inhibition of growth by LTP with ampicillin. The viable colonies can
be observed without microscopic view. The results from the viable count experiment give
rise to further experiments with all the green tea polyphenols.

Figure 18. E coli viable count

3. Kirby Bauer profile study of Gram positive and Gram negative
microorganisms with, GTP, LTP, EGCG, and EGCG-Stearate
The Kirby Bauer method was used to study the effects o f 1% GTP, 1%LTP, 1%
EGCG, and 1% EGCG-Stearate with the combination of 12 antibiotics. This study
reveals very important detail on which antibiotics work best with a certain
microorganism. The inhibition appears to be the greatest with the addition of the green
tea polyphenols, indicating synergism with the antibiotics. Figure 19 reveals the Gram
negative Escherichia coli and the control plate with the applied 12 antibiotics. As seen by
Figure 16 some of the antibiotics have a certain inhibition while others do not have any
inhibition.
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Figure 19. Gram Stain of Escherichia coli and Kirby Bauer Plate
a) Gram stain of Escherichia coli
b) Control plate of Escherichia coli Kirby Bauer Method

Both 1% LTP and 1% GTP were compared with the control for Escherchia coli
and reveal that LTP and GTP have a greater inhibiton than the control antibiotics. Each
test was completed in triplicate to obtain a mean standard devation. LTP has greatest
inhibition with AM 10, BIO, C30, D30, P10 and TE30. Where as GTP has greatest
inhibion with D30, El 5 and GM10. All of the control antibiotics have the lowest zone of
inhibition compared to LTP and GTP except for S10. The zone o f inhibiton is measured
in mm and the highest zone of inhibion observed for Escherchia coli was with the
combination of C30 and 1% LTP, which resulted in a zone o f inhibion to 27 mm. This
great zone of inhibion could be used to determine a future therapeatuic agent that has
both the combination of C30 and LTP. The zone o f inhibition for Escherichia coli were
compared to the control and a percent of inhibition was determined for each antibiotic
with 1% LTP and 1%GTP, as seen in Figure 20a. 1% LTP has the greatest percent of
inhibition for the greatest number of antibiotics. 1%GTP works well with a few
antibiotics but not the majority of the organisms.
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Escherichia coli
|

Control vs. 1% LTP vs. 1% GTP

AM10
■ Control
6
■ LTP
13
■ GTP
6

BIO
6
14
6

CF30
15

C30
14

16
15

27
24

030
8
14
17

E15
6

GM10
18

PIO
6

13
15

23
25

16
6

PB300
6
14
12

RA5
14
12
11

S10
16
14
6

TE30
8
18
14

A n tibiotics

a)

Escherichia coli
Percentage Increase/Decrease fo r 1% LTP & 1%
GTP

-100

-63
A n tib io tics

HLTP H GTP

b)
Figure 20. The Effect of 1% LTP and 1% GTP Treated Escherichia coli with Select
Antibiotics
a) Zone of inhibitions of 1% LTP and 1% GTP Treatment with select Antibiotics
b) Percentage of Increase/Decrease for 1% LTP and 1% GTP Treatments with Select
Antibiotics

AM10(122°/c R
C30 (71% R->S)
S)
BIO
R >S)
D30 (113% R>S)
E15 (122% R >S)
E15(150% R->S)
PIO (161%
PB300(100% R>S)
PB300
R >S)
TE30 (129% R >S)
Table 4. Significant Percent of Inhibitions for Escherichia coli with 1% LTP and 1%
GTP
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The other two compounds EGCG and EGCG-Stearate were observed with
Escherichia coli and compared to each other. Figure 21 reveals that all of the antibiotics
with GTP and LTP inhibit the growth greater than the control except for PB300. 1%
EGCG works best with S10 and EGCG-Stearate works best with E l5 and BIO. The
percentage of inhibition for EGCG and EGCG-Stearate were generated compared to the
control antibiotics. Figure 21a reveals that EGCG-Stearate has the greatest inhibition with
a 167% of inhibition for P10. EGCG has the greatest percentage o f inhibition with a
181% inhibition.

Escherichia coli Control

vs. 1% EGCG vs.

1%

EGCG-Stearate

Antibiotics

330 Escherichia coli Percentage
280

Increase/Decrease

fo r 1% EGCG and 1% EGCG-Stearate

Antibiotics

m EGCG

m EGCG Stearate

Figure 21. The Effect of 1% EGCG and 1% EGCG-Stearate Treated Escherichia coli
with Select Antibiotics
a) Zone of inhibitions of 1% EGCG and 1% EGCG-Stearate Treatment with select
Antibiotics
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b) Percentage of Increase/Decrease for 1% EGCG and 1% EGCG-Stearate Treatments
with Select Antibiotics

AM10 (125% R->S)
D30(106% R->S)
E15(133% R->S)
TE30(180% R->S)

BIO (121% R->S)
P10(167% R->S)
PB300(129% R->S)

Table 5. Significant Percent o f Inhibitions for Escherichia coli with 1% EGCG and 1%
EGCG-Stearate

The next Gram negative organism o f study is Serratia marcescens as shown in
Figure 22. Serratia grown on agar plates appears in a pink tone. The control zones of
inhibition are shown in Figure 22 Kirby Bauer plate. As seen below, many of the
antibiotics alone do not inhibit the growth of Serratia.

Figure 22. Gram Stain of Serratia marcescens and Kirby Bauer Plate
a) Gram stain of Serratia marcescens
b) Control plate of Serratia marcescens Kirby Bauer Method
Serratia was treated with 1% LTP and 1% GTP along with the 12 antibiotics. The
largest zone of inhibition was observed with 1% LTP and C30. 1% LTP was able to
inhibit the growth of Serratia with LTP but not with GTP. Figure 23 shows that GTP
works better than LTP and control for S 10 and GM10. Overall the greatest zone of
inhibition was a result of LTP. The lipophilic green tea polyphenol works well with the
antibiotics. The lipophilic nature of LTP can contribute to its synergistic effects.
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The percentages of inhibition were calculated compared to the control for
Serratia. As seen in Figure 23, LTP works better than GTP in inhibition. The three drugs
that it works synergistically with are BIO, CF30 and RA5. GTP does not synergistically
work well with the antibiotics, as LTP does. As seen in Figure 23, GTP has 0% o f
inhibitions for many of the antibiotics. The greater percentages o f LTP inhibition
indicates that the difference in the molecular structures o f LTP and GTP can play a role
in the interactions with antibiotics. The lipophilic nature o f LTP could contribute to it
working better with the antibiotics against Serratia. Serratia infections are usually
difficult to treat due to its high resistance for many antibiotics on the market. This
research could be used to help treat Serratia infections with a synergistic agent such as
LTP. EGCG and EGCG-Stearate were also treated with the select 12 antibiotics on
Serratia. Again it appears the lipophilic derivative of the green tea polyphenols have the
greatest inhibition rate compared to the less stable compounds. Figure 23a shows that 1%
EGCG-Stearate work best with a majority o f the antibiotics. For many o f the antibiotics
EGCG works equal to the control and does not reveal much synergistic effects.

Serratia marcascens
Control vs. 1% LTP vs. 1% GTP
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Serratia marcascens
Percentage Increase/Decrease for 1% LTP & 1%
GTP

a ltp a gtp

b)
Figure 23. The Effect of 1% LTP and 1% GTP Treated Serratia marcescens with Select
Antibiotics
a) Zone of inhibitions of 1% LTP and 1% GTP Treatment with select Antibiotics
b) Percentage of Increase/Decrease for 1% LTP and 1% GTP Treatments with Select
Antibiotics

I":: M icroorganism |]
j
S . marcescens I

1% LTP
|| 1% GTP
.. lj
BIO (292% R->S)
No significant inhibition
CF30 (119% R->S)
RA5 (225% R->S)
Table 6. Significant Percent of Inhibitions for Serratia marcescens with 1% LTP and 1%
GTP

A percentage of inhibition was determined for both 1% EGCG and 1% EGCGStearate, with EGCG-Stearate demonstrating the greatest percentage o f inhibitions for the
antibiotics. Serratia is an opportunistic pathogen and it is not easy to treat. EGCGStearate resulted in a 183% of inhibition for P10 and a 350% inhibition for CF30. As
observed in Figure 24, EGCG-Stearate has the greatest synergistic effects with the
antibiotics than does EGCG. The synergistic effect observed with 1% EGCG-Stearate
hold many promising therapeutic treatment possibilities.
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Figure 24. The Effect of 1% EGCG and 1% EGCG-Stearate Treated Serratia marcescens
with Select Antibiotics
a) Zone of inhibitions of 1% EGCG and 1% EGCG-Stearate Treatment with select
Antibiotics
b) Percentage of Increase/Decrease for 1% EGCG and 1% EGCG-Stearate Treatments
with Select Antibiotics
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0 (167% R->S)
B10(150% R->S)
C30(143% R->S)
CF30(350% R->S)
P10(183% R->S)
TE30(114% R->S)
Table 7. Significant Percent o f Inhibitions for Serratia marcescens with 1% EGCG and
1% EGCG-Stearate
The Gram negative microorganism, Enterobacter aerogenes is resistant to several
antibiotics just like other enteric bacteria. As seen in Figure 25 from the control Kirby
Bauer Plate the growth o f Enterobacter is not inhibited by many o f the antibiotics.

Figure 25. Gram Stain of Enterobacter aerogenes and Kirby Bauer Plate
a) Gram stain of Enterobacter aerogenes
b) Control plate of Enterobacter aerogenes Kirby Bauer Method
Figure 26 shows the treatment o f 1%GTP and 1% LTP with Enterobacter and the
12 select antibiotics. Enterobacter appears to be inhibited by GTP more than LTP. The
greatest zone of inhibition is observed with 1% GTP and CF30. In this case LTP appears
to inhibit zones of growth similar to the control for a majority o f the antibiotics. The
crude extract GTP inhibits the once resistant Enterobacter. The percentage of inhibition
for Enterobacter with 1% LTP and 1% GTP indicates that GTP works with 12 of the
antibiotics better than LTP. 1% GTP results in a 406% inhibition compared to the control
for AM 10 and a 359% inhibition for CF30. 1% LTP has some negative percentage of
inhibitions indicating it does not inhibit as well as antibiotics alone. The differences in
the GTP and LTP molecular structures could play a role in their synergistic
characteristics with the 12 antibiotics. For TE30 both LTP and GTP have similar
percentages of inhibitions. This initial data indicates that GTP can work synergistically to
treat infections of Enterobacter. The other Gram negative species mentioned previously
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have a greater inhibition percentage with LTP rather than GTP. This is the only Gram
negative organism that has a great inhibition percentage with GTP. This should be further
investigated to observe the mechanism o f action with GTP synergistically inhibiting
Enterobacter.
Enterobacter aerogenes
C o n tro l vs. 1% LTP vs. 1% G T P

■ Control
B LTP
B GTP

AMIO
6
6
30

BIO
7
6
18

CF30
9
6
41

C30
18
14
31

D30
7
7
19

E15
9
20
30

GM10
16
18
28

P10
9
6
32

PB300
6
8
17

RA5
10
13
24

S10
12
18
23

TE30
6
20
20

A n tib io t ic s

a)

Enterobacter aerogenes
Control vs.

1% LTP vs.

1% GTP

Antibiotics

a LTP a GTP

b)
Figure 26. The Effect of 1% LTP and 1% GTP Treated Enterobacter aerogenes with
Select Antibiotics
a) Zone of inhibitions of 1% LTP and 1% GTP Treatment with select Antibiotics
b) Percentage of Increase/Decrease for 1% LTP and 1% GTP Treatments with Select
Antibiotics
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Table 8. Significant Percent of Inhibitions for Enterobacter aerogenes with 1% LTP and
1% GTP
From Figure 27 it is shown that EGCG-Stearate has greater inhibition zones than
EGCG with the exception o f RA5 and BIO. EGCG-Stearate has a great zone o f inhibition
synergistically with C30 with an inhibition zone of 26 mm. The comparisons o f these two
pure extracts from green tea reveal that they are better synergistic agents than LTP and
GTP. With EGCG-Stearate the synergistic effects were observed with at least five
different antibiotics. The percentage of inhibitions for Enterobacter was observed
compared to the control. The percentages reveal that EGCG-Stearate is able to
synergistically inhibit the growth of Enterobacter better than the control antibiotics. Not
all the antibiotic action is enhanced by the two extracts. Figure 30 displays the greatest
percent o f inhibition to be 178% for EGCG and RA5. This particular study can narrow
down the antibiotics that work the best with EGCG and EGCG-Stearate to further study
the interaction with that antibiotic.
Enterobacter aerogenes Control vs.

1% EGCG

vs.

1% EGCG-Stearate

A n tib io tics

a)
43

380

_ 280

Enterobacter aerogenes Percentage
Increase/Decrease fo r 1% EGCG and 1% EGCGStearate

£ 230

Antibiotics

«EGCG « EGCG Stearate

b)
Figure 27. The Effect of 1% EGCG and 1% EGCG-Stearate Treated Enterobacter
areogenes with Select Antibiotics
a) Zone of inhibitions of 1% EGCG and 1% EGCG-Stearate Treatment with select
Antibiotics
b) Percentage of Increase/Decrease for 1% EGCG and 1% EGCG-Stearate Treatments
with Select Antibiotics

AM10 (122% R->S)
B10(l 14% R->S)

AM10 (150% R->S)
P I 0(139% R->S)
PB300(178% R->S)

Table 9. Significant Percent of Inhibitions for Escherichia coli with 1% EGCG and 1%
EGCG-Stearate

Gram positive organisms studied include Bacillus megaterium. Figure 28
demonstrates the rod shaped Bacillus megaterium and the Kirby Bauer plate with certain
successful antibiotics. The Bacillus species are important to study due to their endospore
forming characteristics. They are very resistant in their endospore form and they can
become resistant to many antibiotics.
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Figure 28. Gram Stain of Bacillus megaterium and Kirby Bauer Plate
a) Gram stain of Bacillus megaterium
b) Control plate of Bacillus megaterium Kirby Bauer Method
As seen in Figure 29 the treatment of 1% LTP and 1% GTP is able to inhibit the
growth of Bacillus megaterium better than the control for only several antibiotics. In this
case some of the antibiotics work the same with or without LTP and GTP like S10. The
greatest zone on inhibition observed was for CF30 where the zone o f inhibition with LTP
was 54mm. The greatest zone of inhibition with GTP was observed in combination with
P10. The Bacillus megaterium microorganism is not as susceptible to these drugs as the
other previous mentioned microorganisms. This could be due its large size and the fact
that a greater concentration of the green tea extracts could result in a greater inhibition.
The percent of inhibitions are graphed in Figure 29a and reveal that GTP has the greatest
inhibition percentage o f 112% with BIO. This is compared to the control of BIO alone.
For BIO 1% LTP has a negative effect on the inhibition o f Bacillus megaterium. GTP
also has a negative correlation with PB300 and D30. In these cases the antibiotic inhibits
better without the addition of LTP or GTP. The differences in the action o f LTP and GTP
on the antibiotics could be due to many factors such as the direct molecular interaction
between the two agents. The differences in the LTP and GTP solubility can also play a
role in their degree of inhibition. The lipophilic nature o f LTP can interact with some of
the antibiotics better than GTP. For the several antibiotics that are enhanced by LTP or
GTP, this is very promising for new therapeutic agents that can be based off this
synergism. The addition of these compounds can be applied to these antibiotics and treat
the difficult Bacillus infections.
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Bacillus megaterium
Control vs.

1% LTP vs.

1% GTP

Antibiotics

a)

Bacilus megaterium
Percentage Increase/Decrease for 1% LTP &

M LTP

1% GTP

1 GTP

b)
Figure 29. The Effect of 1% LTP and 1% GTP Treated Bacillus megaterium with Select
Antibiotics
a) Zone of inhibitions of 1% LTP and 1% GTP Treatment with select Antibiotics
b) Percentage of Increase/Decrease for 1% LTP and 1% GTP Treatments with Select
Antibiotics

46

Table 10. Significant Percent of Inhibitions for Bacillus megaterium with 1% LTP and
1% GTP
As seen in Figure 30, Bacillus Megaterium is also treated with 1% EGCG and 1%
EGCG-Stearate in combination with the common antibiotics. These results indicate that
EGCG and EGCG-Stearate do not inhibit the growth any better than the control for a
majority of the antibiotics. BIO synergistically works with EGCG-Stearate to give a zone
of inhibition of 19mm. CF30 also works well with EGCG-Stearate to give a zone of
inhibition of 57mm. The Bacillus megaterium microorganism is the least susceptible of
all the microorganisms from this study. Figure 30a shows that EGCG-Stearate has the
greatest inhibition percentage for BIO with 104%. It is the only one with a percentage
greater than 100%. The other antibiotics work to a certain degree on inhibitions but none
reaching over 50%. This is important information regarding the treatment o f Bacillus
megaterium. It appears is it difficult to treat Bacillus megaterium. The one antibiotic B10
that works the best with EGCG-Stearate should be evaluated for mechanism o f action.
What make this antibiotic work the best with EGCG-Stearate? This could give rise to a
new therapeutic agent for Bacillus megaterium.
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Figure 30. The Effect of 1% EGCG and 1% EGCG-Stearate Treated Bacillus megaterium
with Select Antibiotics
a) Zone of inhibitions of 1% EGCG and 1% EGCG-Stearate Treatment with select
Antibiotics
b) Percentage of Increase/Decrease for 1% EGCG and 1% EGCG-Stearate Treatments
with Select Antibiotics

Table 11. Significant Percent of Inhibitions for Bacillus megaterium with 1% EGCG and
1% EGCG-Stearate

The other Gram positive organism of study, Staphylococcus epidermidis is shown
below in Figure 31. This cocci species is the cause of many multi drug resistant infections
across the globe and needs to be studied. As seen in the Kirby Bauer plate below, it is not
susceptible with a number of antibiotics.
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Figure 31. Gram Stain of Staphylococcus epidermidis and Kirby Bauer Plate
a) Gram stain of Staphylococcus epidermidis
b) Control plate of Staphylococcus epidermidis Kirby Bauer Method

Figure 32 demonstrates the zones of in inhibitions for all controls, LTP and GTP
treated for S. epi. It shows that LTP and GTP work synergistically to for a greater
inhibition zone than the contorl alone. This is seen for all the twelve antibiotics, the
greatest zone of inhibition is seen with AM 10 and P10 with GTP. LTP and GTP have the
same inhibion of 3 1mm for CF30. Below, Figure 32a shows the calculated percent o f
inhibitions with the greatest percentage being 213% for RA5 with GTP. These are all
calculated from a three repeating mean. Five of the antibiotics, AM 10, BIO, C30, P10
and RA5 have greater inhibitions above a 100% with the green tea polyphenols.
Staphylococcus epid e rm id is
C ontrol vs. 1% LTP vs. 1% GTP

A n tib io tics

a)
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Staphylococcus epiderm idis
Percentage Increase/Decrease fo r 1% LTP & 1%
GTP

A n tibiotics

H LTP B GTP

b)
Figure 32. The Effect of 1% LTP and 1% GTP Treated Staphylococcus epidermidis with
Select Antibiotics
a) Zone of inhibitions of 1% LTP and 1% GTP Treatment with select Antibiotics
b) Percentage of Increase/Decrease for 1% LTP and 1% GTP Treatments with Select
Antibiotics

AMIO (103% R->S)
BIO (106% R->S)
C30 (136% R->S)■
P10 (138% R->S)
RA5 (213% R->
Table 12. Significant Percent o f Inhibitions for Staphylococcus epidermidis
with 1% LTP and 1% GTP

With 1% EGCG and 1% EGCG-Stearate the greatest zone of inhibition observed
was 30mm for EGCG with CF30. Figure 39 shows the comparison between EGCG and
EGCG-Stearate compared to the control. It appears that EGCG has greater zones of
inhibitions that EGCG-Stearate. S. epidermidis could interact with the water based GTP
and EGCG better than the lipophilic derivatives. The percentage o f inhibitions compared
to the controls were determined in Figure 33. The percentage o f inhibitions reveal that
EGCG is a better synergistic agent than EGCG-Stearate for S. epidermidis. This could
again be to the molecular structure or EGCG that interacts better than the EGCG-Stearate
with the select drugs.
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Figure 33. The Effect of 1% EGCG and 1% EGCG-Stearate Treated Staphylococcus
epidermidis with Select Antibiotics
a) Zone of inhibitions of 1% EGCG and 1% EGCG-Stearate Treatment with select
Antibiotics
b) Percentage of Increase/Decrease for 1% EGCG and 1% EGCG-Stearate Treatments
with Select Antibiotics
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Table 13. Significant Percent of Inhibitions for Staphylococcus epidermidis
with 1% EGCG and 1% EGCG-Stearate

The last and final microorganism o f study using Kirby Bauer Method is
Mycobacterium smegmatis. This model organism is very important for study due to its
mycolic acid production. Figure 34 shows the stained Mycobacterium smegmatis in its
long bacillus shaped morphology. The Kirby Bauer plates indicate that Mycobacterium
smegmatis is not susceptible to many o f the antibiotics.

Figure 34. Mycobacterium smegmatis and Kirby Bauer Plate
a) Stained Mycobacterium smegmatis
b) Control plate of Mycobacterium smegmatis Kirby Bauer Method

The Figure 35 below reveals the zones o f inhibiton with the LTP and GTP
Treatments. The greatest zone of inhibition is observed for at 39 mm for E l 5 and 1%
GTP treatment. The zones of inhibition vary drastically for all the LTP and GTP treated,
some inhibitng better than others. The percentage of inhibitions shown below in Figure
35a indicates the highest percent of inhibition being 125% which was observed with 1%
LTP in combination with P10 and AM10. Figure 35a also reveals that LTP and GTP
both work equally the same with PB300. For E l 5, the addition of 1% GTP results in a
greater percentage of inhibition at 92%.
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Mycobacterium smegmatis
Control vs. 1% LTP vs. 1% GTP

a)

Mycobacterium smegmatis
Percentage Increase/Decrease of 1% LTP & 1%
GTP
200

Antibiotics

HLTP 1GTP

t>)
Figure 35. The Effect of 1% LTP and 1% GTP Treated Mycobacterium smegmatis with
Select Antibiotics
a) Zone of inhibitions of 1% LTP and 1% GTP Treatment with select Antibiotics
b) Percentage of Increase/Decrease for 1% LTP and 1% GTP Treatments with Select
Antibiotics
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AM10 (125% R->S)
BIO (100% R->S)
P10 (125%)

E15 (92% R->S)

Table 14. Significant Percent o f Inhibitions for Mycobacterium smegmatis with 1% LTP
and 1% GTP

The addition of 1% EGCG and 1% EGCG-Stearate zones o f inhibitions were
measured in Figure 36 below. The greatest zones o f inhibition observed for
Mycobacterium smegmatis is 35mm with EGCG-Stearate and D30. EGCG-Stearate has
the largest zones of inhibitions compared to EGCG and the controls for many o f the
antibiotics. Figure 36a below shows the percent of inhibitions, with the greatest percent
o f inhibition at 194% for PI 0 with EGCG-Stearate. As mentioned above, EGCG-Stearate
works the best in inhibiting with the most number o f antibiotics.

Mycobacterium smegmatis Control vs. 1% EGCG vs. 1%
EGCG-Stearate
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b)
Figure 36. The Effect of 1% EGCG and 1% EGCG-Stearate Treated Staphylococcus
epidermidis with Select Antibiotics
a) Zone of inhibitions of 1% EGCG and 1% EGCG-Stearate Treatment with select
Antibiotics
b) Percentage of Increase/Decrease for 1% EGCG and 1% EGCG-Stearate Treatments
with Select Antibiotics

Table 15. Significant Percent of Inhibitions for Mycobacterium smegmatis
with 1% EGCG and 1% EGCG-Stearate

4. Summary Inhibitions
Table 16 gives an overview summary of inhibition for each microorganism with
1% LTP in combination with the twelve antibiotics. The highlighted cells indicate a
greater than 100% of inhibition. 1% LTP appears to inhibit Escherichia coli,
Enterobacter, Serratia and Mycobacterium smegmatis with the most antibiotics. Table 16
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indicates that 1% LTP in combination with antibiotics inhibits Gram negative
microorganisms better than the Gram negative microorganisms.
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Table 16. 1% LTP Combination Treatment with 12 Select Antibiotics Percent Inhibition
epiderm idis

aerogenes

From Table 17 it is shown that 1% GTP works the best with Enterobacter
aerogenes compared to the other microorganisms. It is able to synergistically work with
all 9 antibiotics with percentages of inhibitions above 100%. The greatest percent of
inhibition for Enterobacter aerogenes is 406%. GTP also works very well with
Staphylococcus epidermidis where it has percentages greater than 100% for five
antibiotics. GTP does not have any synergistic effects for Serratia marcescens.
Escherichia
coli

Enterobacter
aerogenes

Serratia
m arcescens

Staphylococcus
epiderm idis

Bacillus
m egaterium

M ycobacterium
sm egm atis

oy—.
VI

%Inhibition % Inhibition
%Inhibition %Inhibition %Inhibition % Inhibition
55
30
103
0
406
0
AM10
69
112
106
0
162
0
B10
67
5
55
0
359
0
CF30
-49
74
136
0
70
71
C30
27
-15
36
0
167
113
D30
92
28
17
0
237
150
E15
9
9
19
0
73
39
GM10
22
42
138
0
252
0
P10
89
33
-7
0
189
100
PB300
37
45
213
0
137
-25
RAS
20
13
23
0
92
-63
32
23
57
0
228
75
TE30
Table 17. 1% GTP Combination Treatment with 12 Select Antibiotics Percent Inhibition
Summary
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As seen from Table 18,1% EGCG is able to work the best synergistically with the
antibiotics for Escherichia coli and Enterobacter aerogenes. It does not have any
significant inhibition for Serratia marcescens. It is able to work synergistically with
CF30 and P10 for Mycobacterium smegmatis. The greatest percentage o f inhibition is for
Escherichia coli with TE30 at 181%. This particular drug with the combination o f 1%
EGCG can potentially be used to treat Escherichia coli infections.

Table 18. 1% EGCG Combination Treatment with 12 Select Antibiotics Percent
Inhibition Summary

The final summary table with all microorganisms is shown in Table 19. EGCGStearate has a broader range o f synergistic activity. It is able to inhibit the growth of four
microorganisms synergistically. The greatest percentage o f inhibition is observed with
Serratia marcescens at 350% with CF30. EGCG-Stearate is the only polyphenol from
this study that is able to inhibit the growth synergistically with the antibiotics. 1%
EGCG-Stearate affects the growth of five of the microorganisms as opposed to EGCG
which only affects four of the microorganisms. EGCG-Stearate has the greatest range of
activity.
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Table 19. 1% EGCG-Stearate Combination Treatment with 12 Select Antibiotics Percent
Inhibition Summary
Table 20 highlights the microorganisms that were once resistant to the select
antibiotics and become susceptible due to the addition o f 1%LTP, 1% GTP, 1% EGCG
and 1% EGCG-Stearate. It summarizes the effects o f each o f the polyphenols on the
Gram negative and Gram positive microorganisms. From Table 20 it is clear that 1%
EGCG-Stearate works synergistically with at least one antibiotic for all the six
microorganisms. It is also the only one that works against Bacillus megaterium with BIO.
It is able to inhibit with a 104% inhibition, making once resistant Bacillus megaterium
resistant to BIO, now susceptible to it. It is very important to note that only 1% LTP and
1% EGCG-Stearate are able to inhibit the growth o f Serratia marcescens synergistically
with three and six antibiotics, respectively.
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icroorganis;
i

.

i

üj V;

BIO (292% R->S)
CF30 (119% R->S)
RA5 (225% R->S)

No significant inhibition

No significant
inhibition

AM 10 (167% R->S)
BIO (150% R->S)
C30 (143% R->S)
CF30 (350% R->S)
P10 (183% R->S)
TE30 (114% R->S)

AM10 (122% R -> S)
B10 (133% R->S)
E15 (122% R->S)
P10 (161% R->S)
PB300 (128% R->S)
TE30 (129% R->S)

C30 (71% R->S)
D30 (113% R>S)
E l5 (150% R->S)
PB300 (100% R>S)

AM10 (125% R->S)
D30 (106% R->S)
E15 (133% R->S)
TE30 (180% R->S I

BIO (121% R-->S)
P10 (167% R->S)
PB300 (129% R->S)

AM 10 (406% R->S)
E l5 (119% R->S)
TE30 (233% R->S)

BIO (162%R->S),
CF30 (359% R->S),
D30 (167% R->S),
E l 5 (237% R->S),
P10 (252% R->S),
PB300 (189% R->S),
RA5 (137% R->S),
TE30 (228% R->S)

AM10 (122% R->S)
BIO (114% R->S)

AM 10 (150% R->S)
P10 (139% R->S)
PB300 (178% R->S)

P10 (150% R->S)

AM 10 (138% R->S)
CF30 (133% R->S)
P10 (194% R->S)

C30 (133%R->S)
RA5 (113% R->S)

P10 (100% R->S)

No significant
inhibition

B10 (104% R->S)

AM10 (125% R->S)
BIO (100% R->S)
P10 (125%)
C30 (104% R->S)
RA5 (183% R->S)

No significant
inhibition

AM10 (103% R->S),
B10 (106% R->S),
C30 (136% R->S),
P10 (138% R->S),
RA5 (213% R->S)
No significant inhibition

Table 20. Summary Percentage of Inhibition for 1% LTP, GTP, EGCG and EGCGStearate

5. 96 Well Plate Treated Growth Curves
Cultures of Escherichia coli, ampicillin resistant Escherichia coli, Serratia
marcescens, Bacillus megaterium, Staphylococcus aureus, Staphylococcus epidermidis,
and Mycobacterium smegmatis were treated with combination o f ampicillin, 1% EGCG
and 1% EGCG-Stearate to observe their effects on growth over a six hour period. Figure
37 shows the growth curve of Escherichia coli with 1% Ampicillin alone, 1% EGCG
alone, 1% EGCG-Stearate alone, 1% EGCG with Ampicillin or 1% EGCG-Stearate with
Ampicillin. The results demonstrate that 1% EGCG with Ampicillin inhibits the growth
of Escherichia coli completely over the six hour period. Important to note that with 1%
EGCG and 1% EGCG-Stearate alone inhibit the growth compared to the control. In this
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growth curve analysis of Escherichia coli EGCG works better than EGCG-Stearate.
Table 47 displays the growth curve o f ampicillin resistant Escherichia coli with the above
mentioned treatments. 1% EGCG inhibits the growth of ampicillin resistant Escherichia
coli better than 1% EGCG-Stearate, with 0% relative growth. The relative percent growth
was less than that of 1% ampicillin alone. The percent growth for EGCG-Stearate was
random with and without ampicillin. EGCG-Stearate appears not to inhibit the growth
much compared to control but eventually after five hours all cells die and no growth is
observed. The next Gram negative organism observed is Serratia marcescens as seen in
Table 48. The growth of Serratia marcescens is inhibited by 1% EGCG and with 1%
EGCG + Ampicillin the most. This result is different from the Kirby Bauer experiment
where EGCG-Stearate inhibited the growth o f Serratia. This could be due to the fact that
EGCG is applied alone and the growth is observed over the six hours, the EGCG could
have actively inhibited the growth quickly when it is stable, whereas EGCG-Stearate
effects the growth slowly overtime.
The first Gram positive microorganism observed for the growth curve is, Bacillus
megaterium as seen in Table 49. From the growth curves it shows the greatest inhibition
o f growth with Ampicillin alone. 1% EGCG -Stearate inhibits the growth more than
EGCG which agrees with the Kirby Bauer Method experiment. Figure 50 shows the
curves for Staphylococcus epidermidis. For all the treatments 0% growth was observed
except for 1% EGCG-Stearate alone and with ampicillin. This also agrees with the data
from the Kirby Bauer Experiment were EGCG had the greatest effect on Staphylococcus
epidermidis. Table 51 shows the growth for Staphylococcus aureus where there is
complete inhibition with all the treatments except for 1% EGCG-Stearate alone.
Staphylococcus aureus to the treatments with and without ampicillin. A Kirby Bauer
experiment with Staphylococcus aureus should be conducted to further evaluate the
treatment of EGCG and EGCG-Stearate on Staphylococcus aureus. The last
microorganism observed via the growth monitoring is Mycobacterium smegmatis. Table
52 shows that Mycobacterium smegmatis is susceptible to the treatment with 1% EGCG
and with 1% EGCG + Ampicillin compared to the other treatments. 1%EGCG-Stearate
and Ampicillin do not inhibit the growth as much. These results differ from the Kirby
Bauer experiment where EGCG-Stearate and LTP were able to inhibit with other
antibiotics. These growth curves with the difference treatments provide an initial study to
see which green tea polyphenol affects the growth o f the microorganisms.
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Figure 37. Escherichia coli Growth Curve with Ampicillin, 1% EGCG and 1% EGCG-Stearate
a) Escherichia coli Growth Curve with 1% Ampicillin
b) Escherichia coli Growth Curve with 1% EGCG
c) Escherichia coli Growth Curve with 1% EGCG-Stearate
d) Escherichia coli Growth Curve with 1% Ampicillin + 1% EGCG
e) Escherichia coli Growth Curve with 1% Ampicillin + 1% EGCG-Stearate
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Relative Percentage Growth of E. Coli R Control vs. 1%
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Figure 38. Escherichia coli R Growth Curve with Ampicillin, 1% EGCG and 1% EGCGStearate
a) Escherichia coli R Growth Curve with 1% Ampicillin
b) Escherichia coli R Growth Curve with 1% EGCG
c) Escherichia coli R Growth Curve with 1% EGCG-Stearate
d) Escherichia coli R Growth Curve with 1% Ampicillin + 1% EGCG
e) Escherichia coli R Growth Curve with 1% Ampicillin + 1% EGCG-Stearate
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Figure 39. Serratia marcescens Growth Curve with Ampicillin, 1% EGCG and 1%
EGCG-Stearate
a) Serratia marcescens Growth Curve with 1% Ampicillin
b) Serratia marcescens Growth Curve with 1% EGCG
c) Serratia marcescens Growth Curve with 1% EGCG-Stearate
d) Serratia marcescens Growth Curve with 1% Ampicillin + 1% EGCG
e) Serratia marcescens Growth Curve with 1% Ampicillin + 1% EGCG-Stearate
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Figure 40. Bacillus megaterium Growth Curve with Ampicillin, 1% EGCG and 1%
EGCG-Stearate
a) Bacillus megaterium Growth Curve with 1% Ampicillin
b) Bacillus megaterium Growth Curve with 1% EGCG
c) Bacillus megaterium Growth Curve with 1% EGCG-Stearate
d) Serratia marcescens Growth Curve with 1% Ampicillin + 1% EGCG
e) Serratia marcescens Growth Curve with 1% Ampicillin + 1% EGCG-Stearate
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Figure 41. Staphylococcus epidermidis Growth Curve with Ampicillin, 1% EGCG and
1% EGCG-Stearate
a) Staphylococcus epidermidis Growth Curve with 1% Ampicillin
b) Staphylococcus epidermidis Growth Curve with 1% EGCG
c) Staphylococcus epidermidis Growth Curve with 1% EGCG-Stearate
d) Staphylococcus epidermidis Growth Curve with 1% Ampicillin + 1% EGCG
e) Staphylococcus epidermidis Growth Curve with 1% Ampicillin + 1% EGCG-Stearate
65

Figure 42. Staphylococcus aureus Growth Curve with Ampicillin, 1% EGCG and 1%
EGCG-Stearate Combination Treatments
a) Staphylococcus aureus Growth Curve with 1% Ampicillin
b) Staphylococcus aureus Growth Curve with 1% EGCG
c) Staphylococcus aureus Growth Curve with 1% EGCG-Stearate
d) Staphylococcus aureus Growth Curve with 1% Ampicillin + 1% EGCG
e) Staphylococcus aureus Growth Curve with 1% Ampicillin + 1% EGCG-Stearate
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Figure 43. Mycobacterium smegmatis Growth Curve with Ampicillin, 1% EGCG and 1%
EGCG-Stearate Combination Treatments
a) Mycobacterium smegmatis Growth Curve with 1% Ampicillin
b) Mycobacterium smegmatis Growth Curve with 1% EGCG
c) Mycobacterium smegmatis Growth Curve with 1% EGCG-Stearate
d) Mycobacterium smegmatis Growth Curve with 1% Ampicillin + 1% EGCG
e) Mycobacterium smegmatis Growth Curve with 1% Ampicillin + 1% EGCG-Stearate
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6. Endospore Inhibition Study
With the growing concern of endospores in the food and medical industry the study of
Bacillus megaterium endospores with the green tea polyphenols is very valuable for a
possible treatment. First the endospores in Bacillus megaterium need to be triggered and
isolated for this study. Nutrient agar with the addition o f 0.06 g o f MgS 04 and 0.25 g of
KH 2PO 4 per liter of media preparation. The endospores are isolated after ten days and
seen in Figure 44.

Figure 44. Endospore crop grown on modified nutrient agar lOOx
The endospores were treated with 10% GTP and 10% LTP were plated for a
viable count. The results are shown in Figure 45 where the numbers o f endospores that
germinate to vegetative cells after treatment grow into colonies. The number o f
endospores treated with 10% LTP and 10% GTP inhibit the germination o f the
endospores compared to the control. Figure 46 shows the plates treated with 1%, 5% and
10% EGCG-Stearate. As seen by the viable count the treated endospores with EGCGStearate work to inhibit the germination of the endospores compared to the control.
Figure 47 shows the 10% treatment o f EGCG on the endospores. All o f the polyphenols
result in an inhibition of germination. This initial data can be used to further study the
effect of endospore germination to vegetative cells on more serious endospore forming
microorganisms such as Bacillus cereus. The green tea polyphenols are able to inhibit the
endospores from turning into vegetative cells. This could have major implications in the
food industry to prevent endospore spoilage and infection.
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Figure 45. 10% GTP and 10% LTP Treated Bacillus megaterium Endospore
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Figure 46. 1%, 5% and 10% EGCG-Stearatp Treated Bacillus megaterium Endospores
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Figure 47. 10% EGCG Treated Bacillus megaterium Endospores
Tables 21 to 23 summarizes the effect of the green tea polyphenols on the
endospores. As seen by Table 23 the greatest average % inhibition o f the endospores
germinating was from the treatment of 10% EGCG. With the increasing concentration of
EGCG-Stearate the percent o f inhibition also increases from 70.5% to 79.0% o f
endospore inhibition, as shown in Table 22. From the calculated average inhibition in
table 21, is it shown that 10% LTP works better than 10% GTP in inhibition o f endospore
germination. These results are very important for further studies with inhibiting
endospores from turning into harmful vegetative cells. If green tea polyphenols can be
used to treat current endospores in the food industry or medical field, they can prevent
many infections and serve as a method of treatment. Endospores in general are difficult to
eradicate, and the promising results of this endospore study gives rise to many further
analysis of endospore inhibition with green tea polyphenols.
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Control
10% GTP
10% LTP

IO'2 (CFU)
2480
1160
320

10‘3(CFU)
944
236
44

Avg. % Inhibition
—

64.1%
91%

Table 21. Treatment of 10% GTP and 10% LTP on endospore germination

Control
1% EGCG-Stearate
5% EGCG-Stearate
10% EGCG-Stearate

10’*(CFU)
224
66
56
47

% Inhibition
-

70.5%
75.0%
79.0%

Table 22. Treatment o f 1%, 5%, and 10% EGCG-Stearate on endospore germination

10 3 (CFU)

10"1(CFU) Avg. % Inhibition

Control

8

5

--

10% EGCG

0

0

100%

Table 23. Treatment of 10% EGCG on endospore germination

7. Biofilm Study
The dangers of microorganism forming biofilms and becoming highly resistant to
once susceptible treatments are alarming. The follow experiment o f forming a biofilm
with two common biofilm organisms, Pseudomonas aeruginosa and Pseudomonas
fluorescens were investigated. Figure 57 shows the growth o f Pseudomonas aeruginosa
in row one of the 24 well plate and the growth of Pseudomonas fluorescens in the second
row. The biofilm was grown by using Trypticase broth and allowed to grow for a 72 hour
period. Figure 58 shows the biofilm attached cells stained with crystal violet. The stain
allows for viewing the number of cells that actually formed the biofilm. Three repeatings
for each microorganism was conducted.
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P. aeruginosa

P. fluorescens

Figure 48. Pseudomonas aeruginosa and Pseudomonas fluorescens Biofilm Formations
on 6 Well Plate

P. aeruginosa

P. fluorescens

Figure 49. Pseudomonas aeruginosa and Pseudomonas fluorescens Biofilm Formations
on 6 Well Plate with Crystal Violet Stain
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A growth curve was generated for the biofilm formed by Pseudomonas
aeruginosa over the 72 hour period as seen in Figure 50 below. The growth increase until
it reaches a peak at day three. Figure 51 shows the growth o f the biofilm over 72 hours
for Pseudomonas fluorescens, which does not grow as well as Pseudomonas aeruginosa.
Pseudomonas aeruginosa reaches an OD6ooup to 0.2A whereas Pseudomonas fluorescens
only reaches an ODgoo of 0.12 A which is about half o f the growth of Pseudomonas
aeruginosa. This data is used to determine Pseudomonas aeruginosa as the model
organism of choice to study the effects o f the green tea polyphenols on the biofilm.
Additionally, two genes have been identified in Pseudomonas aeruginosa, acpP and
PhzAl which are involved in the formation of biofilms. The regulation of these genes
will be observed with the treatment o f EGCG and EGCG-Stearate.

Pseudomonas aeruginosa Biofilm Formation

Time (Hrs)

Figure 50. Pseudomonas aeruginosa Biofilm Formations over 72 Hour Period

Pseudomonas fluorescens Biofilm Formation

Time (Hrs)

Figure 51. Pseudomonas fluorescens Biofilm Formations over 72 Hour Period
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As seen in Figure 52 with the increasing treatment o f both LTP and GTP, the
number of Pseudomonas aeruginosa cells is significantly less than the control. This in
initial study on biofilm treatment could be used to further study the effects o f green tea
polyphenols on biofilm formations. Table 24 shows a percent of inhibition o f biofilm
growth for 1% LTP to be 31.4% and for 1% GTP to be 29.8%.

0.5% GTP

0.5% LTP

1% GTP

1% LTP

Control

Figure 52. Microscopic observation of air-liquid interface assay o f Pseudomonas
aeruginosa with 0.5% GTP, 0.5% LTP, 1% GTP, and 1% LTP

75

Day

Tryptic Broth
%Biofilm Growth

%Biofilm
Inhibition

0
1
2

0

0

85.46

0

92.55

0

3

100

0

Day

1% GTP
% Biofilm Growth

%Biofilm
Inhibition

0
1
2

0

0

83.5

16.5

78.7

21.3

3

70.2

29.8

Day

1% LTP
% Biofilm Growth

%Biofilm
Inhibition

0
1
2

0

0

80

20

71.8

28.2

3

68.6

31.4

Table 24. Percent of Biofilm Inhibition with and without Treatment o f GTP and LTP

76

V.

Conclusion

Through the numerous experiments conducted with green tea polyphenols, it can
be concluded that green tea polyphenols work synergistically with specific antibiotics to
inhibit the growth of microorganisms. 1% EGCG or EGCG-Stearate with or without 1%
ampicillin inhibited the growth for more than 50% of the microorganisms. Minimum
inhibitory concentration was determined for each green tea polyphenol derivative via
micro dilution broth method. The minimum inhibitory concentration was determined to
be 1% for the majority o f the microorganisms. This is why all the concentrations used 1%
for the treatment except for the endospore study since endospores are highly resistant to
any treatment.
1% GTP, LTP, EGCG and EGCG-Stearate are used in combination with twelve
selected antibiotics; Ampicillin (AM10), Bacitracin (BIO), Cephalothin (CF30),
Chloramphenicol (C30), Doxycycline (D30), Erythromycin (E l5), Gentamicin (GM10),
Penicillin (P10), Polymyxin (PB300), Rifampin (RA5), Streptomycin (S10), and
Tetracycline (TE30) resulted in many combination effects and demonstrated potential
targets o f study. With 1% GTP there was no significant percentage o f inhibition for S.
marcescens and B. megaterium. 1% GTP had the greatest percent o f inhibition in
synergism with CF30 for E. aerogenes. In the presence o f 1% LTP, 11 antibiotics showed
increased (24 to 122%) antimicrobial activity on S. epidermidis, only PB300 showed
lightly decrease (8%) in activity when compare with antibiotics alone. In the presence of
1% LTP, nine antibiotics showed increased (22 to 188%) activity on E. coli, LTP has no
effect on RA5, but decreased the activity o f CF30 (-27%), AM 10 (-33%) on E. coli. LTP
in M. smegmatis, E. aerogenes, B. megaterium, and S. marcescens showed synergistic
effect on different antibiotics. LTP increased 100% efficacy o f PI 0 on M smegmatis;
increased 122% efficacy of El 5 and 117% efficacy o f TE30 on E. aerogenes; increased
50% efficacy o f C30 in B. megaterium; increased 300% efficacy o f B10 and 233% of
RA5 in S. marcescens. The results suggested that synergistic effect o f 1% EGCG varied
depending upon microorganisms and antibiotics used against particular microorganisms.
In the presence o f 1% EGCG, E. aerogenes revealed the greatest increase (19-150%) in
antimicrobial activities with all antibiotics. S. epidermidis and E. coli showed similar
increases (30-133% and 18-181% respectively) in activity, with an exception of PB300
on S. epidermidis (-46%) and CF30 on E. coli (-17%). EGCG in M. smegmatis and B.
megaterium showed some synergistic and antagonistic effect on different antibiotics.
EGCG increased efficacy of B10, CF30, and P I0 on M. smegmatis (86%-150%). For 1%
EGCG-Stearate the greatest percent of inhibition was seen in S. marcescens. EGCGStearate is the only agent that was able to synergistically work with multiple antibiotics to
inhibit the growth of S. marcescens. EGCG-Stearate works synergistically with at least
one antibiotic for all the studied microorganisms.
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Endospore forming bacteria particularly o f the Bacillus species have overtaken
the food industry with dangers o f resistance to modem treatments. This study also
observed Bacillus megaterium endospore preparation and purification methods. Once
purified, the treatment of GTP, LTP, EGCG and EGCG-Stearate were observed. 10%
LTP treatment resulted in an average o f 91% inhibition of spomlation compared to
control endospores. 10% GTP treatment resulted in an average o f 64.1% inhibition. 10%
EGCG resulted in a 100% inhibition compared to 10% EGCG-Stearate, which showed
79% inhibition.
The initial biofilm experiment showed promising results with the treatment o f
0.5% GTP, 0.5% LTP, 1% GTP and 1% LTP. It was observed that with increasing
treatment of both LTP and GTP, the number of Pseudomonas aeruginosa cells is less
than the control. The percent o f inhibition o f biofilm growth for 1% LTP to be 31.4% and
for 1% GTP to be 29.8%. This inhibition indicates that the green tea polyphenols are able
to prevent the formation of the biofilm to a certain extent.
These board studies o f the endless benefits of green tea polyphenols give rise to
many medicinal implications. From these results, it can be concluded that LTP, GTP,
EGCG and EGCG-Stearate are antimicrobial agents with EGCG and EGCG-Stearate
being the most effective agent. Purified green tea polyphenols can be used as synergistic
agents to modem antibiotics and have a wide range o f other uses. The potential usage o f
green tea polyphenols can be of great benefit to the pharmaceutical industry.
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VI.

Future Studies

Molecular biology techniques will be used to observe the mechanism behind
the actions of the green tea polyphenols as antimicrobial, anti-sporulation and
anti-biofilm agents. To study the biofilm formation under the treatment o f EGCG
and EGCG-Stearate, the Pseudomonas aeruginosa genes will be observed. The
two genes acpP and phzA l will be analyzed in Pseudomonas aeruginosa via Real
Time PCR analysis. The expression of these biofilm forming genes will be
observed under the conditions o f green tea polyphenol treated and non-treated. It
will be determined if these genes are down-regulated or up-regulated after each
treatment. This method will determine if the green tea polyphenols actually effect
gene expression.
The exact mechanism o f action of the tea polyphenols in synergism with
antibiotics will be determined. The mechanism of action will be determined via
studies using TEM and SEM. Whether the cell walls are a target o f interest will be
determined. The lipophilic nature of EGCG-Stearate and LTP interacts will the
microorganisms, differently than the other derivatives. Specifically how EGCGStearate is able to inhibit the growth o f Serratia marcescens will be determined.
Potential topical application o f the lipophilic derivatives will be evaluated.
Future studies of the spore study will determine how the green tea
polyphenols can inhibit germination of the endospores into vegetative cells. The
genes involved in endospore formation and germination will also be evaluated
using Real Time PCR. This data can be used to create potential anti-germination
products for endospores. In the near future the lab hopes to incorporate the
findings of this research into pharmaceutical grade topical potential treatments.
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